249 related articles for article (PubMed ID: 12810644)
21. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
[TBL] [Abstract][Full Text] [Related]
22. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma.
Shimato S; Natsume A; Takeuchi H; Wakabayashi T; Fujii M; Ito M; Ito S; Park IH; Bang JH; Kim SU; Yoshida J
Gene Ther; 2007 Aug; 14(15):1132-42. PubMed ID: 17508009
[TBL] [Abstract][Full Text] [Related]
23. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models.
Himeno Y; Etoh T; Matsumoto T; Ohta M; Nishizono A; Kitano S
Int J Oncol; 2005 Oct; 27(4):901-6. PubMed ID: 16142304
[TBL] [Abstract][Full Text] [Related]
25. Reovirus as an oncolytic agent against experimental human malignant gliomas.
Wilcox ME; Yang W; Senger D; Rewcastle NB; Morris DG; Brasher PM; Shi ZQ; Johnston RN; Nishikawa S; Lee PW; Forsyth PA
J Natl Cancer Inst; 2001 Jun; 93(12):903-12. PubMed ID: 11416111
[TBL] [Abstract][Full Text] [Related]
26. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
Rancourt C; Bergeron C; Lane D; Garon G; Piché A
Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
[TBL] [Abstract][Full Text] [Related]
27. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA
Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938
[TBL] [Abstract][Full Text] [Related]
28. A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model.
Horiuchi H; Kawamata H; Fujimori T; Kuroda Y
Int J Oncol; 2003 Oct; 23(4):957-63. PubMed ID: 12963974
[TBL] [Abstract][Full Text] [Related]
29. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
[TBL] [Abstract][Full Text] [Related]
30. Reovirus oncolysis of human breast cancer.
Norman KL; Coffey MC; Hirasawa K; Demetrick DJ; Nishikawa SG; DiFrancesco LM; Strong JE; Lee PW
Hum Gene Ther; 2002 Mar; 13(5):641-52. PubMed ID: 11916487
[TBL] [Abstract][Full Text] [Related]
31. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM
Cancer Res; 2003 Sep; 63(17):5521-5. PubMed ID: 14500389
[TBL] [Abstract][Full Text] [Related]
32. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Canron X; Bikfalvi A; Martuza RL; Kurtz A; Rabkin SD
Clin Cancer Res; 2006 Nov; 12(22):6791-9. PubMed ID: 17121900
[TBL] [Abstract][Full Text] [Related]
33. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
34. A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus.
Fu X; Tao L; Cai R; Prigge J; Zhang X
Mol Ther; 2006 May; 13(5):882-90. PubMed ID: 16569513
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic reovirus against ovarian and colon cancer.
Hirasawa K; Nishikawa SG; Norman KL; Alain T; Kossakowska A; Lee PW
Cancer Res; 2002 Mar; 62(6):1696-701. PubMed ID: 11912142
[TBL] [Abstract][Full Text] [Related]
37. Vaccinia virus mediated p53 gene therapy for bladder cancer in an orthotopic murine model.
Fodor I; Timiryasova T; Denes B; Yoshida J; Ruckle H; Lilly M
J Urol; 2005 Feb; 173(2):604-9. PubMed ID: 15643273
[TBL] [Abstract][Full Text] [Related]
38. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
39. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.
Strong JE; Coffey MC; Tang D; Sabinin P; Lee PW
EMBO J; 1998 Jun; 17(12):3351-62. PubMed ID: 9628872
[TBL] [Abstract][Full Text] [Related]
40. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]